AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.29
+0.27 (2.69%)
At close: Jun 26, 2026, 4:00 PM EDT
10.32
+0.03 (0.29%)
After-hours: Jun 26, 2026, 7:31 PM EDT

Company Description

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States.

It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.

The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies.

It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies.

The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

AdaptHealth Corp.
AdaptHealth logo
Country United States
Founded 2012
Industry Medical Devices
Sector Healthcare
Employees 10,900
CEO Suzanne Foster

Contact Details

Address:
555 East North Lane, Suite 5075
Conshohocken, Pennsylvania 19428
United States
Phone 610 424 4515
Website adapthealth.com

Stock Details

Ticker Symbol AHCO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001725255
CUSIP Number 00653Q102
ISIN Number US00653Q1022
Employer ID 82-3677704
SIC Code 8082

Key Executives

Name Position
Suzanne M. Foster M.P.H. Chief Executive Officer and Director
Jason A. Clemens C.F.A. Chief Financial Officer
Albert A. Prast Chief Technology Officer and Chief Innovation Officer
Russell E. Schuster III Chief Commercial Officer
Daniel McFadden Chief Operations Officer
Christine E. Archbold Chief Accounting Officer
Nalin Narayanam Chief Information Officer
Wendy Russalesi Chief Compliance Officer
Richard W. Rew II Chief Legal Officer, General Counsel and Secretary
Kelly Morgan Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Jun 22, 2026 8-K Current Report
Jun 2, 2026 8-K/A [Amend] Current report
Jun 1, 2026 144 Filing
May 5, 2026 10-Q Quarterly Report
May 5, 2026 8-K Current Report
Apr 28, 2026 ARS Filing
Apr 28, 2026 DEF 14A Other definitive proxy statements
Apr 13, 2026 8-K Current Report
Apr 9, 2026 SCHEDULE 13G Filing
Mar 26, 2026 SCHEDULE 13G/A Filing